(Q36303892)

13 August 2017

1 reference

title

Recognition and management of digitalis toxicity (English)

1 reference

Cardiology and cardiovascular medicine

13 August 2017

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

17 October 2022

author name string

R. A. Kelly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626485

17 October 2022

T. W. Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626485

17 October 2022

language of work or name

English

0 references

publication date

1 June 1992

1 reference

13 August 2017

4 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1626485

full work available at URL

17 October 2022

https://api.elsevier.com/content/article/PII:0002914992912597?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

https://api.elsevier.com/content/article/PII:0002914992912597?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

American Journal of Cardiology

17 October 2022

published in

1 reference

13 August 2017

69

1 reference

13 August 2017

108G-118G; disc. 118G-119G

1 reference

13 August 2017

18

1 reference

Intensive Hospital Monitoring of Adverse Reactions to Drugs

13 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Digitalis intoxication. A prospective clinical study with serum level correlations

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Relation between digoxin arrhythmias and ABO blood groups. Boston Collaborative Drug Surveillance Program

17 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

An outbreak of digoxin intoxication

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay

17 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Plasma digoxin measurements and the assessment of extracardiac symptoms of toxicity [proceedings]

17 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Comparison of Serum Digoxin Level Measurement with Acetyl Strophanthidin Tolerance Testing

17 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988.

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Life-threatening digitalis intoxication with and without additional diuretic treatment (author's transl)

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Correlative studies of serum digitalis levels and the arrhythmias of digitalis intoxication

17 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Digoxin-prescribing. Mostly good news

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration

17 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Digitalis-associated cardiac mortality after myocardial infarction

17 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Effect of digitalis treatment on survival after acute myocardial infarction

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

The effects of digitalis on survival in high-risk patients with coronary artery disease. The Coronary Artery Surgery Study (CASS).

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Prognostic importance of digitalis after acute myocardial infarction

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial

17 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

The electrophysiological effects of ouabain on sinus node and atrium in man

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Paroxysmal Atrial Tachycardia with Block

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Cardiac glycosides and congestive heart failure

17 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Effects of denervation on sodium, potassium and [3H]ouabain binding in muscles of normal and potassium-depleted rats.

17 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Frequency of hypomagnesemia in hospitalized patients receiving digitalis

17 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Effects of digitalis on resting and isometric exercise myocardial perfusion in patients with coronary artery disease and left ventricular dysfunction

17 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Combined Propranolol and Digoxin Therapy in Angina Pectoris

17 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study

17 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Immunologic treatment of digitalis toxicity: a tale of two prophecies

17 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study

17 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Review of clinical experience with digoxin immune Fab (ovine).

17 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. The Digibind Study Advisory Panel.

17 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Risk factors and manifestations of digoxin toxicity in the elderly

17 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Results of multicenter studies of digoxin-specific antibody fragments in managing digitalis intoxication in the pediatric population

17 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Experience with digoxin immune Fab (ovine) in patients with renal impairment

17 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Which cardiac disturbances should be treated with digoxin immune fab (ovine) antibody?

17 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Recognition and management of digitalis intoxication: implications for emergency medicine

17 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Digitalis intoxication or intrinsic conduction system disease

17 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Cost-effectiveness analysis of the use of digoxin immune Fab(ovine) for treatment of digoxin toxicity

17 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study

17 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study

17 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

Life-threatening hyperkalemia in severe heart failure

17 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91259-7

17 October 2022

Identifiers

1 reference

13 August 2017

1 reference